EyeSouth Partners, a portfolio company of Shore Capital Partners, has acquired Georgia Ophthalmology Associates, a provider of medical and surgical specialty eye care services. No financial terms were disclosed.
ATLANTA, December 8, 2017 – EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has expanded in the Atlanta metropolitan area by completing a strategic partnership with Georgia Ophthalmology Associates. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity firm.
Georgia Ophthalmology Associates was founded in 1978 by Dr. Stephen Leff and offers a full suite of medical and surgical specialty eye care services including cataract surgery, LASIK, glaucoma treatment, oculoplastics and medical optometry. Georgia Ophthalmology Associates is led by a team of four board-certified physicians and a licensed optometrist, who provide care at two clinical locations in Decatur and Snellville, Georgia.
“Georgia Ophthalmology Associates and EyeSouth share a similar mission of providing high quality medical and surgical eye care to patients,” said Dr. Gayle Goldstein of Georgia Ophthalmology Associates. “I am excited to embark upon our next phase of growth with the support of EyeSouth. The partnership will enable us to further execute our strategy of optimizing our patients experience through our commitment to clinical quality, cutting edge technologies, industry-leading physician expertise, and best-in-class administrative support. We have always loved practicing in a very personal manner and will continue to maintain close relationships with our patients and their referring doctors.”
For nearly 40 years, Georgia Ophthalmology Associates has offered high quality eye care treatment services to patients throughout the Atlanta metropolitan area. Georgia Ophthalmology Associates will continue to operate under its brand in the community with no changes to its underlying staff, physicians or locations.
“We are thrilled to have a practice with Georgia Ophthalmology Associates’ reputation for clinical excellence and patient service join the EyeSouth network,” said Scott Bullock, President of EyeSouth’s Anterior Division. “We look forward to partnering with the physicians and support team at Georgia Ophthalmology Associates to provide additional resources and expertise to enhance patient care and continue the practice’s history of growth.”
EyeSouth’s affiliate network consists of 30 doctors providing medical and surgical eye care services at 20 locations throughout Georgia.
To learn more about a partnership with EyeSouth Partners, visit www.eyesouthpartners.com or contact Charlie Shreve, VP of Business Development & Strategy, email@example.com.
About EyeSouth Partners
Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care physician services organization committed to partnering with leading physicians to build a premier network of eye care services in Georgia and the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with capital, administrative resources, operating expertise, and strategic guidance with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of 30 doctors practicing at 20 locations in Georgia. EyeSouth is backed by Shore Capital Partners, a leading lower middle market healthcare private equity firm. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.
About Shore Capital Partners
Shore Capital is a Chicago-based private equity firm focused exclusively on microcap healthcare investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has approximately $600 million of equity capital under management through various investment vehicles. For more information, please visit: www.shorecp.com.